Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02315248 · ClinicalTrials.gov registry record
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
A clinical trial, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 197
- Enrollment target
NCT02315248 is a clinical trial that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 197 participants.
The verdict
NCT02315248 has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to validate a human saliva sample analyzer technique designed to screen for low bone density and osteoporosis. The analyzer technique is meant to be a simple, noninvasive, easy-to-use, cost-effective, and routine means of diagnosing bone turnover using a point-of-care device that monitors salivary markers of bone turnover in a screening patient population that is at risk for low bone density or osteoporosis.
Interventions
- RADIATION Quantitative computed tomography scan for bone density analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02315248
The ClinicalTrials.gov registry entry for NCT02315248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quantitative computed tomography scan for bone density analysis is the first listed.
NCT02315248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02315248 about?
NCT02315248 is a clinical study titled "Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study". The purpose of this study is to validate a human saliva sample analyzer technique designed to screen for low bone density and osteoporosis. The analyzer technique is meant to be a simple, noninvasive, easy-to-use, cost-effective, and routine means of diagnosing bone turnover using a point-of-care de...
What is the current status of trial NCT02315248?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2014-12. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02315248?
The interventions under investigation include: Quantitative computed tomography scan for bone density analysis (RADIATION).
Who is sponsoring clinical trial NCT02315248?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.